임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Type 2 Diabetes MellitusA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
리드: 아스트라제네카
- 1상모집 중· Staphylococcus Aureus Bloodstream InfectionA Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults
리드: 아스트라제네카
- 단계 미표기모집 중· Atypical Hemolytic Uremic SyndromeRavulizumab Outcomes in Polish Patients With aHUS
리드: 아스트라제네카
- 단계 미표기모집 중· Lung CancerReal-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
리드: 아스트라제네카
- 3상모집 중· ER-Positive HER2-Negative Breast CancerA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
리드: 아스트라제네카
- 2상모집 중· Non-Small Cell Lung CancerPneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
협력: 아스트라제네카
- 2상모집 중· Idiopathic Pulmonary Fibrosis (IPF)A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
리드: 아스트라제네카
- 해당없음모집 중· Suspected AsthmaExplore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
리드: 아스트라제네카
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 1/2상모집 중· Metastatic Prostate CancerPhase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 해당없음모집 중· Non-Small Cell Lung CancerA Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)
리드: 아스트라제네카
- 4상모집 중· Non-small Cell Lung CancerOsimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
리드: 아스트라제네카
- 1/2상모집 중· Metastatic Prostate CancerFirst-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
리드: 아스트라제네카
- 4상모집 중· Severe AsthmaTezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
협력: 아스트라제네카
- 2상모집 중· Advanced Breast CancerStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
리드: 아스트라제네카
- 3상모집 중· Chronic Obstructive Pulmonary DiseaseLong-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
리드: 아스트라제네카
- 3상모집 중· Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHVSurovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
리드: 아스트라제네카
- 3상모집 중· Metastatic Castration-resistant Prostate CancerAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
리드: 아스트라제네카
- 2상모집 중· Antiphospholipid Syndrome (APS)Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
협력: 아스트라제네카
- 2상모집 중· Adenoid Cystic CarcinomaPhase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
협력: 아스트라제네카
- 단계 미표기모집 중· Non-Small-Cell LungA Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
리드: 아스트라제네카
- 3상모집 중· Chronic Rhinosinusitis With Nasal PolypsA Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
리드: 아스트라제네카
- 단계 미표기모집 중· Gynaecological CancersGYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian Cohort
리드: 아스트라제네카
- 단계 미표기모집 중· Hepatocellular CarcinomaMONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
리드: 아스트라제네카
- 3상모집 중· Systemic Lupus ErythematosusA Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
리드: 아스트라제네카
- 단계 미표기모집 중· HyperkalemiaObservational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
리드: 아스트라제네카
- 단계 미표기모집 중· HypertensionObservational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System
리드: 아스트라제네카
- 2상모집 중· Primary Membranous NephropathyA Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
리드: 아스트라제네카
- 1상모집 중· Hepatic ImpairmentA Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
리드: 아스트라제네카
- 단계 미표기모집 중· Lupus Erythematosus, SystemicNIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
리드: 아스트라제네카
- 단계 미표기모집 중· Chronic Rhinosinusitis With Nasal PolypsA Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
리드: 아스트라제네카
- 단계 미표기모집 중· Pan-tumor(NSCLC, GYN Cancers, BTC and UC)A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
리드: 아스트라제네카
- 해당없음모집 중· COPD (Chronic Obstructive Pulmonary Disease)Enhanced COPD Management in Suspected Lung Cancer Patients
협력: 아스트라제네카
- 4상모집 중· Acute Coronary Syndromes (ACS)Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
협력: 아스트라제네카
- 단계 미표기모집 중· Non-Small Cell Lung CancerCHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC
리드: 아스트라제네카
- 단계 미표기모집 중· Chronic Kidney DiseaseA Prospecitve Multicenter, Observational Registry Study
리드: 아스트라제네카
- 1상모집 중· EGFR Mutation-positive NSCLCPhase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
리드: 아스트라제네카
- 3상모집 중· Relapsed Refractory Multiple MyelomaA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
리드: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.